Neurobiological Advances in Addiction Science: Implications For Prevention and Treatment Nora D. Volkow, M.D. Director

Size: px
Start display at page:

Download "Neurobiological Advances in Addiction Science: Implications For Prevention and Treatment Nora D. Volkow, M.D. Director"

Transcription

1 Neurobiological Advances in Addiction Science: Implications For Prevention and Treatment Nora D. Volkow, M.D.

2 Drugs and Natural Rewards ACTIVATE Dopamine in Reward Regions % of Basal Release % of Basal Release frontal cortex nucleus accumbens VTA/SN AMPHETAMINE hr Time After Amphetamine 2 FOOD 15 Drugs of abuse increase DA in the Nucleus Accumbens, which is believed to trigger the neuroadaptions that result in addiction 1 5 Empty Box Feeding Time (min) Di Chiara et al.

3 Repeated Drug Use Changes the Brain Weakens the Brain Dopamine System Control Cocaine Abuser T Y R O S I N E T Y R O S I N E T Y R O S I N E DA D O P A DA D O P A DA D O P A COCAINE PLEASURE REPEATED USE OF COCAINE OR OTHER DRUGS REDUCES LEVELS OF DOPAMINE D2 RECEPTORS

4 Bmax/Kd DA D2 Receptors (Ratio Index) Dopamine D2 Receptors are Lower in Addiction 4.5 Normal Controls Cocaine Abusers Cocaine Meth Alcohol 3.2` Heroin control addicted Volkow et al., Neuro Learn Mem

5 John Smith James Smith Ann Jones ThomasSmith AnneCook John Jones Mary Hill John Smith EdwardSmith JaneWalker JamesCook Beth Bryson Walter Jones Alice Price James Hill Susan Edwards John Walker JaneJones JonathanCook Amy Mason Edward Bryson Beth Carter Thomas Jones Rebecca Wilson William Price Alice Benson Richard Hill Mary Walters Steven Adams Susan Adams Allison Fields Addiction Involves Multiple Factors DEVELOPMENT/Genes ENVIRONMENT DRUG Brain Mechanisms Addiction

6 % age group who develop first-time cannabis use disorder The Brain Undergoes Major Changes From Childhood Through Adulthood 1.6% 1.4% 1.2% 1.%.8%.6%.4%.2% Dynamic Sequence of GM Maturation.% Age Age at cannabis use disorder as per DSM IV NIAAA National Epidemiologic Survey on Alcohol and Related Conditions, 23 Gogtay et al. 24 Proc. Natl. Acad. Sci. USA 11,

7 Social Rank & Vulnerability to Drugs Dominant 3 months Social Deprivation Interferes with Brain Connectivity Social Neglect During Early Childhood Decreases Brain Connectivity Individual Housed Subordinate 3 months Group Housed Individual Housed * * Group Housed Dominant Subordinate 1 S Cocaine (mg/kg/inj) Morgan, D. et al. Nature Neuroscience, 5: , 22. Decreased connectivity between amygdala and OFC wass proportional to time in orphanage. Govindan et al., Cereb Cortex 21.

8 Reduce these Elevate these Prevention Programs Should Enhance Protective Factors & Reduce Risk Factors

9 ADDICTION CAN BE TREATED Partial Recovery of Brain Dopamine Transporters in Methamphetamine (METH) Abuser After Protracted Abstinence 3 ml/gm Normal Control METH Abuser (1 month detox) METH Abuser (14 months detox) Source: Volkow, ND et al., Journal of Neuroscience 21, , 21.

10 Medications Assisted Therapies Opioid Agonist Treatments Decreased Heroin OD Deaths Baltimore, Maryland, Methadone Promotes Initiation Of Antiretroviral Therapy in IDU Heroin overdoses Buprenorphine patients Methadone patients Schwartz RP et al., Am J Public Health 213. Uhlmann S et al., Addiction 21; 15(5):

11 Around the World WORLD DRUG REPORT 216, UNODC

12 Challenge: How to Integrate Drug Abuse & Addiction Screening, Prevention & Treatment into the Healthcare System

13

14 Days Improving Treatments for Addiction: Implementing Medication-Assisted Treatment Emergency department-initiated buprenorphine Reduced self-reported, illicit opioid use Increased engagement in addiction treatment; decreased use of inpatient addiction treatment services Self-Reported Illicit Opioid Use in the Past 7 Days Baseline 3 days Buprenorphine Referral Brief Intervention

15 Childhood Self-Control Predicts Health (Dunedin Study; 1 children) Children with low self-control had poorer health outcomes and higher problems with substance use disorders than those with high self-control Moffitt et al., PNAS 211. Interventions that Aid Executive Function In 4 to 12 Years Olds Self-control can be improved by: Computerized training Non-computerized games Aerobics Martial Arts Yoga Mindfulness School Curricula All successful programs involved repeated practice and progressively increase challenge to executive function Diamond & Lee. Science 211.

16 Medications are Underused In 48 states and D.C., Opioid Abuse and Dependence Rates Exceed Buprenorphine Treatment Capacity In 214, the proportion of opioid admissions with tx plans that included receiving medications was 25% Jones C et al., Am J Public Health 215. Nearly all U.S. states do not have sufficient treatment capacity to provide medication assisted treatment to all patients with an opioid use disorder [VAL UE] MAT [VAL UE] No MAT Treatment Episode Data Set (TEDS):

17 Microstructural Abnormalities in Language and Limbic Pathways in Orphanage-Reared Children: A Diffusion Tensor Imaging Study Relationship between language function and Fractional Anisotropy (FA) for the left arcuate fasciculus in children with early deprivation Increases in FA are associated with better language function Association of mean diffusivity of the left arcuate fasciculus and time spent in the adoptive home Mean diffusivity decreased with increasing time spent in the adoptive environment Kumar A et. al., J Child Neurology 214; 29(3):

18 Duration Of Early Adversity and Structural Brain Development In Post-institutionalized Adolescents Prefrontal gray matter volume (age & sex adjusted) is reduced in PI youth Duration of early adversity predicts hippocampal volume reduction (age and sex adjusted) Duration of adversity over first year of life predicts hippocampal volume (age, sex, and ICV adjusted) in early adolescence (right hippocampal effect is equivalent). Hodel AS et al., Neuroimage. 215 Jan 15;15:

19 Effect of Early Institutionalization and Foster Care on Long-Term White Matter Development Multimodal Regression Models Examining Effects of Intervention Neglect in early life was associated with alterations in white matter microstructure throughout the brain, specifically involving the body of the corpus callosum, cingulum, fornix, anterior and superior corona radiata, external capsule, retrolenticular internal capsule, and medial lemniscus. The foster care group did not significantly differ from the never-institutionalized group in measurements of these tracts, with the exception of the body of the corpus callosum and superior corona radiata. These findings suggest a potential for remediation of specific white matter pathways for children removed from institutional care and placed in responsive families early in life. Bick J et al., JAMA Pediatr 215 Mar; 169(3):

20 Metabolism CG (micromol/1g/min) Metabolism OFC (micromol/1g/min) Frontal Metabolism Metabolism Prefrontal Chronic Drug Use Reduces DA D2 Receptors Impairing Frontal Function DA DA DA DA DA signal DA DA DA D2 Receptors Metabolism Control Controls Controls Cocaine Abuser Methamphetamine Abusers Alcoholics D2R VS (Bmax/Kd) D2 Receptors (BP ND ) D2R VS (Bmax/Kd) D2 Receptors (BP ND ) 3. 4

Neurobiological Advances in Addiction Science: Implications For Treatment Nora D. Volkow, M.D. Director

Neurobiological Advances in Addiction Science: Implications For Treatment Nora D. Volkow, M.D. Director Neurobiological Advances in Addiction Science: Implications For Treatment Nora D. Volkow, M.D. Director @NInews Concentration ) Dopamine (nm) Drugs and Natural Rewards ACTIVATE Dopamine in Reward Regions

More information

Science = Solutions. Carlos Blanco, M.D., Ph.D. Director, Division of Epidemiology, Services and Prevention Research National Institute on Drug Abuse

Science = Solutions. Carlos Blanco, M.D., Ph.D. Director, Division of Epidemiology, Services and Prevention Research National Institute on Drug Abuse Advancing Addiction Science Science = Solutions Carlos Blanco, M.D., Ph.D. Director, Division of Epidemiology, Services and Prevention Research National Institute on Drug Abuse John Smith James Smith Ann

More information

Understanding Addiction and Its Impact on the Brain. SDSMA Webinar Matthew Stanley, DO

Understanding Addiction and Its Impact on the Brain. SDSMA Webinar Matthew Stanley, DO Understanding Addiction and Its Impact on the Brain SDSMA Webinar Matthew Stanley, DO Estimated Economic Cost to Society Due to Substance Abuse and Addiction: Illegal drugs: Alcohol: Tobacco: $181 billion/year

More information

Bringing the full power of science to bear on Drug Abuse & Addiction

Bringing the full power of science to bear on Drug Abuse & Addiction ational nstitute on rug buse Bringing the full power of science to bear on Drug Abuse & Addiction Nora D. Volkow, M.D. Director National Institute on Drug Abuse John Smith James Smith Ann Jones ThomasSmith

More information

Effects of Marijuana On Brain, Body & Behavior. Nora D. Volkow, M.D. Director

Effects of Marijuana On Brain, Body & Behavior. Nora D. Volkow, M.D. Director Effects of Marijuana On Brain, Body & Behavior Nora D. Volkow, M.D. Director Marijuana is the Most Commonly Used Illicit Drug In the U.S. Over 111 million Americans have tried it at least once An estimated

More information

The Brain, Behavior and Addiction National Family Dialogue January 27, 2010 Presenter: Flo Hilliard, MSH University of Wisconsin-Madison

The Brain, Behavior and Addiction National Family Dialogue January 27, 2010 Presenter: Flo Hilliard, MSH University of Wisconsin-Madison The Brain, Behavior and Addiction National Family Dialogue January 27, 2010 Presenter: Flo Hilliard, MSH University of Wisconsin-Madison Attitudes about addiction and recovery throughout history Disease?

More information

Effects of Marijuana On Brain, Body & Behavior. Nora D. Volkow, MD Director

Effects of Marijuana On Brain, Body & Behavior. Nora D. Volkow, MD Director Effects of Marijuana On Brain, Body & Behavior Nora D. Volkow, MD Director Marijuana is the Most Commonly Used Illicit Drug In the U.S. Over 111 million Americans have tried it at least once An estimated

More information

The Role of NEUROIMAGING In Diagnostic and Clinical Practice

The Role of NEUROIMAGING In Diagnostic and Clinical Practice The Role of NEUROIMAGING In Diagnostic and Clinical Practice ADHD Schizophrenia Autism Addiction Altzheimer s Disease Nora D. Volkow, M.D. Director National Institute on Drug Abuse National Institutes

More information

Brain Health and Opioid Abuse

Brain Health and Opioid Abuse 2018 Statewide Tribal Opioid Summit Brain Health and Opioid Abuse Healing From Opiate Addiction Requires Comprehensive Approaches Psychological, Socio-Cultural, and Biological Donald R. Vereen, Jr., M.D.,

More information

Addiction as a Neuropsychiatric Medical Condition

Addiction as a Neuropsychiatric Medical Condition Addiction as a Neuropsychiatric Medical Condition Wilson M. Compton, M.D., M.P.E. Director, Division of Epidemiology, Services and Prevention Research National Institute on Drug Abuse 5 November 2009 Summary

More information

Brain, Pain, Opioids. John Hart, DO

Brain, Pain, Opioids. John Hart, DO Brain, Pain, Opioids CHANGE John Hart, DO 4 % Rule 1 UDS Pain score Contract & PMP Ask about addiction Ak Ask about tfunction As long as function increases, there is no upper limit to opioid UDS Pain

More information

Noel Schenk MD. Davis Behavioral Health

Noel Schenk MD. Davis Behavioral Health Noel Schenk MD Davis Behavioral Health Michael Botticelli Director of National Drug Control Policy What is Addiction? Addiction is defined as a chronic, relapsing brain disease that is characterized by

More information

The Neurobiology of Addiction

The Neurobiology of Addiction The Neurobiology of Addiction Jodi Gilman, Ph.D. Center for Addiction Medicine Massachusetts General Hospital Associate Professor, Department of Psychiatry Harvard Medical School What is Addiction? commonly

More information

The Biology of Addiction

The Biology of Addiction The Biology of Addiction Risk factors for addiction: Biological/Genetic Family history of addiction Being male Having mental illness Exposure to substances in utero * The genes that people are born with

More information

Connection Between Prevention and Recovery

Connection Between Prevention and Recovery Connection Between Prevention and Recovery Jessica Herrmann, Governor s Institute on Substance Abuse Jimmy Cioe, Governor s Institute on Substance Abuse Chris Campau, NC State Collegiate Recovery Community

More information

Effects of Marijuana On Brain, Body & Behavior. Nora D. Volkow, MD Director

Effects of Marijuana On Brain, Body & Behavior. Nora D. Volkow, MD Director Effects of Marijuana On Brain, Body & Behavior Nora D. Volkow, MD Director Marijuana is the Most Commonly Used Illicit Drug In the U.S. Over 111 million Americans have tried it at least once An estimated

More information

Brain Imaging studies in substance abuse. Jody Tanabe, MD University of Colorado Denver

Brain Imaging studies in substance abuse. Jody Tanabe, MD University of Colorado Denver Brain Imaging studies in substance abuse Jody Tanabe, MD University of Colorado Denver NRSC January 28, 2010 Costs: Health, Crime, Productivity Costs in billions of dollars (2002) $400 $350 $400B legal

More information

Marijuana is the Most Commonly Used Illicit Drug In the U.S.

Marijuana is the Most Commonly Used Illicit Drug In the U.S. Effects of Marijuana On Brain, Body & Behavior Marijuana is the Most Commonly Used Illicit Drug In the US Nora D Volkow, MD Director Over million Americans have tried it at least once An estimated million

More information

The Science of Drug Addiction: Implications for Clinical Practice

The Science of Drug Addiction: Implications for Clinical Practice The Science of Drug Addiction: Implications for Clinical Practice Jack B. Stein, Ph.D. Director Office of Science Policy and Communications National Institute on Drug Abuse National Institutes of Health

More information

The Science of Addiction

The Science of Addiction The Science of Addiction Immersion Training in Addiction Medicine Program 2018 April 23, 2018 Daniel P. Alford, MD, MPH Professor of Medicine Associate Dean, Continuing Medical Education Director, Clinical

More information

The Neurobiology of Drug Addiction

The Neurobiology of Drug Addiction The Neurobiology of Drug Addiction Glen R. Hanson, Ph.D., D.D.S. Director, Utah Addiction Center Professor of Pharmacology and Toxicology, U of U Senior Advisor, NIDA Drug Abuse and Addiction are Among

More information

Update on Medications for Tobacco Cessation

Update on Medications for Tobacco Cessation Update on Medications for Tobacco Cessation Marc Fishman MD Johns Hopkins University Dept of Psychiatry Maryland Treatment Centers Baltimore MD MDQuit Best Practices Conference Jan 2013 Nicotine Addiction

More information

What Is Heroin? Examples of Opioids. What Science Says about Opioid Use Disorder and Its Treatment 6/27/2016

What Is Heroin? Examples of Opioids. What Science Says about Opioid Use Disorder and Its Treatment 6/27/2016 What Science Says about Opioid Use Disorder and Its Treatment Perilou Goddard, Ph.D. Department of Psychological Science Northern Kentucky University Examples of Opioids Agonists (activate opioid receptors)

More information

The Science of Addiction

The Science of Addiction This is the property of 2016 CRIT/FIT. Permission is required to duplicate. The Science of Addiction CRIT/FIT 2016 April 24-27, 2016 Daniel P. Alford, MD, MPH Associate Professor of Medicine Assistant

More information

Medication Supported Recovery- A Review of Evidence-Based Practice

Medication Supported Recovery- A Review of Evidence-Based Practice Medication Supported Recovery- A Review of Evidence-Based Practice Andrew B. Mendenhall, MD, DABAM, DABFM, Senior Medical Director, Substance Use Disorder Services, Central City Concern 1 Objectives 1.

More information

The opioid crisis: A view from NIDA

The opioid crisis: A view from NIDA The opioid crisis: A view from NIDA National Institute on Drug Abuse Bringing the full power of of science to bear to bear on drug on drug abuse abuse and addiction and addiction Nora D. Volkow, M.D. Director

More information

Eighth Edition. Part I: Current Science of Addiction, Relapse & Recovery: Dispelling The Stigmas

Eighth Edition. Part I: Current Science of Addiction, Relapse & Recovery: Dispelling The Stigmas Eighth Edition Part I: Current Science of Addiction, Relapse & Recovery: Dispelling The Stigmas 1 < < < Evolution of our Human Brain: Spinal Cord to Diencephalon to Mammalian-Meso Cortex to Neo Cortex

More information

What are Substance Use Disorders?

What are Substance Use Disorders? What are Substance Use Disorders? Sanchit Maruti, MD Michael Goedde, MD University of Vermont Medical Center 1 Disclosures } Drs. Maruti and Goedde receive compensation as consultants to the American Academy

More information

Opiate Use Disorder and Opiate Overdose

Opiate Use Disorder and Opiate Overdose Opiate Use Disorder and Opiate Overdose Irene Ortiz, MD Medical Director Molina Healthcare of New Mexico and South Carolina Clinical Professor University of New Mexico School of Medicine Objectives DSM-5

More information

The Opioid Epidemic and Youth Prescription Drug Abuse. Sandy Chung, MD Chair, Board of Trustees Virginia Foundation for Healthy Youth

The Opioid Epidemic and Youth Prescription Drug Abuse. Sandy Chung, MD Chair, Board of Trustees Virginia Foundation for Healthy Youth The Opioid Epidemic and Youth Prescription Drug Abuse Sandy Chung, MD Chair, Board of Trustees Virginia Foundation for Healthy Youth Disclosures: I have no relevant financial relationships with the manufacturer(s)

More information

Buprenorphine is the most effective office-based treatment available for heroin and prescription opioid addiction

Buprenorphine is the most effective office-based treatment available for heroin and prescription opioid addiction Buprenorphine is the most effective office-based treatment available for heroin and prescription opioid addiction The Problem The overdose death rate in Missouri and in the country has been rising for

More information

Neurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP

Neurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP Neurobiology of Addiction JeanAnne Johnson Talbert, DHA, APRN BC, FNP, CARN AP Disclosures This speaker has no conflicts of interest to disclose Objectives Define drug abuse and addiction Identify the

More information

Is DTI Increasing the Connectivity Between the Magnet Suite and the Clinic?

Is DTI Increasing the Connectivity Between the Magnet Suite and the Clinic? Current Literature In Clinical Science Is DTI Increasing the Connectivity Between the Magnet Suite and the Clinic? Spatial Patterns of Water Diffusion Along White Matter Tracts in Temporal Lobe Epilepsy.

More information

590,000 deaths can be attributed to an addictive substance in some way

590,000 deaths can be attributed to an addictive substance in some way Mortality and morbidity attributable to use of addictive substances in the United States. The Association of American Physicians from 1999 60 million tobacco smokers in the U.S. 14 million dependent on

More information

THE PHYSIOLOGY OF ADDICTION

THE PHYSIOLOGY OF ADDICTION THE PHYSIOLOGY OF ADDICTION Effects of Drug-Taking Behavior on the Brain Ruth A. Potee, MD Family Physician & Addictionologist, Valley Medical Group Medical Director, Franklin County House of Corrections

More information

Council on Chemical Abuse Annual Conference November 2, The Science of Addiction: Rewiring the Brain

Council on Chemical Abuse Annual Conference November 2, The Science of Addiction: Rewiring the Brain Council on Chemical Abuse Annual Conference November 2, 2017 The Science of Addiction: Rewiring the Brain David Reyher, MSW, CAADC Behavioral Health Program Director Alvernia University Defining Addiction

More information

The Science of Drug Addiction: Implications for Clinical Practice

The Science of Drug Addiction: Implications for Clinical Practice The Science of Drug Addiction: Implications for Clinical Practice Jack B. Stein, Ph.D. Director Office of Science Policy and Communications National Institute on Drug Abuse National Institutes of Health

More information

The Neuroscience of Addiction: A mini-review

The Neuroscience of Addiction: A mini-review The Neuroscience of Addiction: A mini-review Jim Morrill, MD, PhD MGH Charlestown HealthCare Center Massachusetts General Hospital Disclosures Neither I nor my spouse/partner has a relevant financial relationship

More information

The Science of Addiction: Prescription Opioid Abuse. Wilson M. Compton, M.D., M.P.E. Deputy Director, National Institute on Drug Abuse

The Science of Addiction: Prescription Opioid Abuse. Wilson M. Compton, M.D., M.P.E. Deputy Director, National Institute on Drug Abuse The Science of Addiction: Prescription Opioid Abuse Wilson M. Compton, M.D., M.P.E. Deputy Director, National Institute on Drug Abuse Key Points: 1. Prescription opioid abuse is a major problem in USA

More information

Adolescent Brain Development and Drug Abuse. Ken C. Winters, Ph.D. Professor, Department of Psychiatry, University of Minnesota

Adolescent Brain Development and Drug Abuse. Ken C. Winters, Ph.D. Professor, Department of Psychiatry, University of Minnesota Adolescent Brain Development and Drug Abuse New findings indicate that brain development still in progress during adolescence; immature brain structures may place teenagers at elevated risk of substance

More information

The Opiate Crisis 4/6/18. April 9, Words are important. If you want to care for something, you call it a flower.

The Opiate Crisis 4/6/18. April 9, Words are important. If you want to care for something, you call it a flower. The Opiate Crisis Presented by Dr. Anahi Ortiz Franklin County Coroner April 9, 2018 Words are important. If you want to care for something, you call it a flower. If you want to kill something, you call

More information

The Science of Addiction: The Brain on Adolescence

The Science of Addiction: The Brain on Adolescence The Science of Addiction: The Brain on Adolescence Ken Winters, Ph.D. Senior Scientist, Oregon Research Institute & Adjunct Faculty, Dept. of Psychology, University of Minnesota winte001@umn.edu December

More information

Opioid Epidemic Update

Opioid Epidemic Update Opioid Epidemic Update - 2018 Talal Khan MD Addiction Psychiatrist Pine Rest What are Opioids? Opiates are alkaloid compounds naturally found in the opium Poppy plant. Papaver somniferum The psychoactive

More information

Quality assurance in pharmacotherapy with methadone

Quality assurance in pharmacotherapy with methadone Quality assurance in pharmacotherapy with methadone Dr. Emilis Subata Vilnius Centre for Addictive Disorders Psychiatry Clinic of Vilnius University emilis.subata@vplc.lt Outline of the presentation Introduction

More information

MOLECULAR BIOLOGY OF DRUG ADDICTION. Sylvane Desrivières, SGDP Centre

MOLECULAR BIOLOGY OF DRUG ADDICTION. Sylvane Desrivières, SGDP Centre 1 MOLECULAR BIOLOGY OF DRUG ADDICTION Sylvane Desrivières, SGDP Centre Reward 2 Humans, as well as other organisms engage in behaviours that are rewarding The pleasurable feelings provide positive reinforcement

More information

Facing Addiction: Key Terms Use Any use of any substance. Driven by market forces. Misuse Use that can harm self or others. Driven by consequences.

Facing Addiction: Key Terms Use Any use of any substance. Driven by market forces. Misuse Use that can harm self or others. Driven by consequences. Facing Addiction: Surgeon General s Report on Reducing Misuse and Addiction A.Thomas McLellan Senior Editor Key Terms Use Any use of any substance. Driven by market forces Misuse Use that can harm self

More information

Neurobiology of Addiction

Neurobiology of Addiction Neurobiology of Addiction Tiffany Love, Ph.D. Department of Psychiatry The University of Utah What is Addiction? Addiction is a chronic, relapsing, and treatable brain disorder. Compulsive drug seeking

More information

THE CHRONIC DISEASE OF ADDICTION. J.A. Samander, M.D.

THE CHRONIC DISEASE OF ADDICTION. J.A. Samander, M.D. THE CHRONIC DISEASE OF ADDICTION J.A. Samander, M.D. OBJECTIVES Review of chronic, relapsing model of addiction Comparison with other chronic diseases Lessons from patients Addiction 24.6 million adults

More information

MARIJUANA & THE EFFECTS ON THE BRAIN

MARIJUANA & THE EFFECTS ON THE BRAIN MARIJUANA & THE EFFECTS ON THE BRAIN Sheryl Ryan, MD Professor of Pediatrics Chief, Division of Adolescent Medicine, Penn State Health Hershey Medical Center DISCLOSURES I have no relevant financial relationships

More information

Shawn A. Ryan MD, MBA President & Chief Medical Officer Board Certified, Addiction Medicine

Shawn A. Ryan MD, MBA President & Chief Medical Officer Board Certified, Addiction Medicine [Patient-focused, evidence-based addiction treatment] Shawn A. Ryan MD, MBA President & Chief Medical Officer Board Certified, Addiction Medicine BrightView Health All Rights Reserved www.brightviewhealth.com

More information

Discover the Hope: Opiate Treatment and Recovery

Discover the Hope: Opiate Treatment and Recovery Discover the Hope: Opiate Treatment and Recovery The Continued Struggle to Find and Implement Best Practices Ted Parran JR. M.D. FACP Carter and Isabel Wang Professor of Medical Education CWRU School of

More information

Learning outcomes: Keeping it Real and Safe: What Every School Counselor Should Know About Underage Drinking

Learning outcomes: Keeping it Real and Safe: What Every School Counselor Should Know About Underage Drinking Keeping it Real and Safe: What Every School Counselor Should Know About Underage Drinking Aaron White, PhD - NIAAA April 18, 2018 Learning outcomes: Current trends in underage drinking How does alcohol

More information

Brain Imaging Studies on the Cognitive, Pharmacological and Neurobiological Effects of Cannabis in Humans: Evidence from Studies of Adult Users

Brain Imaging Studies on the Cognitive, Pharmacological and Neurobiological Effects of Cannabis in Humans: Evidence from Studies of Adult Users Send Orders for Reprints to reprints@benthamscience.ae REVIEW ARTICLE Current Pharmaceutical Design, 2016, 22, 1-14 1 Brain Imaging Studies on the Cognitive, Pharmacological and Neurobiological Effects

More information

Neurobiology of Addiction

Neurobiology of Addiction Neurobiology of Addiction Cindy Miner, Ph.D. Deputy Director Office of Science Policy and Communications National Institute on Drug Abuse National Institutes of Health Department of Health and Human Services

More information

The Impact of Research on the Care of Addicted Patients. Update. Nora D. Volkow, M.D. Director National Institute on Drug Abuse

The Impact of Research on the Care of Addicted Patients. Update. Nora D. Volkow, M.D. Director National Institute on Drug Abuse The Impact of Research on the Care of Addicted Patients A Update Nora D. Volkow, M.D. Director National Institute on Drug Abuse HISTORY - previous history - expectation - learning DRUGS BIOLOGY - genetics

More information

Medication Assisted Treatment: Right for you, Right for your Recovery? Robert Matylewicz, DO, FASAM Medical Director, Clarity Way Inc.

Medication Assisted Treatment: Right for you, Right for your Recovery? Robert Matylewicz, DO, FASAM Medical Director, Clarity Way Inc. Medication Assisted Treatment: Right for you, Right for your Recovery? Robert Matylewicz, DO, FASAM Medical Director, Clarity Way Inc. Elements Behavioral Health Diplomate, American Board of Addiction

More information

The Neurobiology of Street Drugs. Joe Gilboy PA-C Hoag Hospital Emergency Department Irvine, CA. Neuroplasticity. Question #1

The Neurobiology of Street Drugs. Joe Gilboy PA-C Hoag Hospital Emergency Department Irvine, CA. Neuroplasticity. Question #1 The Neurobiology of Street Drugs Joe Gilboy PA-C Hoag Hospital Emergency Department Irvine, CA Question #1 Neuroplasticity is the new field of neurobiology that is based upon which of the following : 1.

More information

MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER

MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER Melissa B. Weimer, DO, MCR Chief of Behavioral Health & Addiction Medicine St. Peter s Health Partners Grand Rounds October 11, 2017 Disclosures One

More information

Psychotropic Drugs Critical Thinking - KEY

Psychotropic Drugs Critical Thinking - KEY Open Your Class with This Tomorrow Chasing the Scream: The First and Last Days of the War on s Psychotropic s Critical Thinking - KEY Background: The blood-brain barrier is a network of tightly packed

More information

Neurocognition and Neuroimaging Correlates of Persistent Negative Symptoms. Cindy Hovington Dr. Martin Lepage

Neurocognition and Neuroimaging Correlates of Persistent Negative Symptoms. Cindy Hovington Dr. Martin Lepage Neurocognition and Neuroimaging Correlates of Persistent Negative Symptoms Cindy Hovington Dr. Martin Lepage NEGATIVE SYMPTOMS Anhedonia Loss of Pleasure Asociality Decreased Social Drive Avolition Lack

More information

Effects of Drugs on the Brain and Behavior in Adolescents

Effects of Drugs on the Brain and Behavior in Adolescents Effects of Drugs on the Brain and Behavior in Adolescents Lucas Moore, LCSW, SAC-IT Adolescent Substance Abuse Treatment Coordinator July 20, 2015 Wisconsin Department of Health Services Today What would

More information

BRAIN MECHANISMS OF REWARD AND ADDICTION

BRAIN MECHANISMS OF REWARD AND ADDICTION BRAIN MECHANISMS OF REWARD AND ADDICTION TREVOR.W. ROBBINS Department of Experimental Psychology, University of Cambridge Many drugs of abuse, including stimulants such as amphetamine and cocaine, opiates

More information

NIDA Research. Advances in Drug Abuse and Addiction from NIDA: Implications for Treatment

NIDA Research. Advances in Drug Abuse and Addiction from NIDA: Implications for Treatment Advances in Drug Abuse and Addiction from NIDA: Implications for Treatment Timothy P. Condon, Ph.D. Deputy Director National Institute on Drug Abuse National Institutes of Health Department of Health and

More information

Understanding the Brain: What Drugs Can Tell Us

Understanding the Brain: What Drugs Can Tell Us LIVE INTERACTIVE LEARNING @ YOUR DESKTOP Understanding the Brain: What Drugs Can Tell Us Presented by: Dr. Rochelle D. Schwartz-Bloom March 24, 2011 Understanding the Brain: What Drugs Can Tell Us Rochelle

More information

Policy Implications of the Neurobiology of Addiction

Policy Implications of the Neurobiology of Addiction Policy Implications of the Neurobiology of Addiction Facilitator: Jay Butler, MD, President of ASTHO, Chief Medical Officer Alaska Department of Health and Social Services Director, Alaska Division of

More information

Neuroscience of Addiction

Neuroscience of Addiction Neuroscience of Addiction Carlton Erickson, Ph.D. Associate Dean for Research and Graduate Studies Distinguished Professor of Pharmacology Director, Addiction Science Research and Education Center College

More information

Addiction. Concept of Addiction R. Corey Waller MD, MS, FACEP, FASAM Director, Center for Integrative Medicine

Addiction. Concept of Addiction R. Corey Waller MD, MS, FACEP, FASAM Director, Center for Integrative Medicine Addiction Concept of Addiction R. Corey Waller MD, MS, FACEP, FASAM Director, Center for Integrative Medicine Twitter: @rcwallermd Objectives Understand the Concept of Addiction Survival FOOD WATER DOPAMINE

More information

THE SCIENCE OF RECOVERY: AN ADVANCED SEMINAR. CARDWELL C. NUCKOLS, PhD

THE SCIENCE OF RECOVERY: AN ADVANCED SEMINAR. CARDWELL C. NUCKOLS, PhD THE SCIENCE OF RECOVERY: AN ADVANCED SEMINAR CARDWELL C. NUCKOLS, PhD cnuckols@elitecorp1.com KINTSUKUROI KINTSUKUROI Kintsukuroi (keen-tsoo-koo-roy) is the Japanese art of repaired pottery. But it's something

More information

The Adolescent Developmental Stage

The Adolescent Developmental Stage The Adolescent Developmental Stage o Physical maturation o Drive for independence o Increased salience of social and peer interactions o Brain development o Inflection in risky behaviors including experimentation

More information

Listen & Hear 4Lo

Listen & Hear   4Lo Mark Lim M.D FASAM Medical Director NorthLakes Community Clinic Recovery Program Board Certified in Family Medicine Board Certified in Addiction Medicine mlim@northlakesclinic.org 7156852200 Listen & Hear

More information

Pregnancy, MAT and Addiction

Pregnancy, MAT and Addiction Pregnancy, MAT and Addiction Carl Christensen, MD, PhD, D-FASAM Clinical Associate Professor, OB Gyn & Psychiatry Wayne State University School of Medicine William Morrone, DO, MPH, DABAM Covenant Hospital

More information

UNDERSTANDING THE DISEASE OF ADDICTION by Suresh Joseph

UNDERSTANDING THE DISEASE OF ADDICTION by Suresh Joseph UNDERSTANDING THE DISEASE OF ADDICTION by Suresh Joseph Summary of Presentation Addiction as a disease Medical harm of substance use Treatment models for substance dependence Local support services for

More information

Medication Assisted Treatment of an Opioid Use Disorder. J. Craig Allen, MD. Medical Director, Rushford

Medication Assisted Treatment of an Opioid Use Disorder. J. Craig Allen, MD. Medical Director, Rushford Medication Assisted Treatment of an Opioid Use Disorder J. Craig Allen, MD. Medical Director, Rushford Learning objectives At the conclusion of this activity, participants will be able to: Understand

More information

OPIOID USE DISORDER AND THE PSYCHIATRIC EMERGENCY ROOM THE VA CT MODEL

OPIOID USE DISORDER AND THE PSYCHIATRIC EMERGENCY ROOM THE VA CT MODEL OPIOID USE DISORDER AND THE PSYCHIATRIC EMERGENCY ROOM THE VA CT MODEL Brian Fuehrlein, MD PhD VA Connecticut Healthcare System and Yale University I have no conflicts of interest or relevant financial

More information

How Addiction Affects the Brain: The Neuroscience of Compulsive Behavior

How Addiction Affects the Brain: The Neuroscience of Compulsive Behavior How Addiction Affects the Brain: The Neuroscience of Compulsive Behavior Table of Contents INTRODUCTION.... 3 NEUROSCIENCE 101: NEURONS AND NEUROTRANSMITTERS.... 4 BRAIN REGIONS INVOLVED IN ADDICTION:

More information

THE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE. Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept.

THE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE. Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept. THE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept. Public Health disclosures Dr. Martin has no conflict of interest to disclose.

More information

Supporting Parents in Your Essential Role in Youth Substance Use Prevention

Supporting Parents in Your Essential Role in Youth Substance Use Prevention Supporting Parents in Your Essential Role in Youth Substance Use Prevention P A R E N T U N I V E R S I T Y * R YE, N EW Y O R K M AY 9, 2 0 1 7 R O B E R T L. D UP O N T, M D P R E S I D E N T I N S T

More information

Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center

Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center Data from the National Vital Statistics System Mortality The age-adjusted rate of drug overdose deaths in the United States

More information

MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER Melissa B. Weimer, DO, MCR Chief of Behavioral Health & Addiction Medicine St.

MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER Melissa B. Weimer, DO, MCR Chief of Behavioral Health & Addiction Medicine St. MANAGING PAIN IN PATIENTS WITH SUBSTANCE USE DISORDER Melissa B. Weimer, DO, MCR Chief of Behavioral Health & Addiction Medicine St. Peter s Health Partners, Albany, NY Assistant Professor of Medicine,

More information

Medical Interventions for Addiction in Primary Care Settings. R. Douglas Bruce, MD, MA, MSc Assistant Professor Yale University School of Medicine

Medical Interventions for Addiction in Primary Care Settings. R. Douglas Bruce, MD, MA, MSc Assistant Professor Yale University School of Medicine Medical Interventions for Addiction in Primary Care Settings R. Douglas Bruce, MD, MA, MSc Assistant Professor Yale University School of Medicine March 23, 2010 NIH Consensus on Drug Treatment Drug Addiction

More information

Opioid Use Disorder Treatment Initiation in Diverse Settings

Opioid Use Disorder Treatment Initiation in Diverse Settings Opioid Use Disorder Treatment Initiation in Diverse Settings Sarah Wakeman, MD, FASAM Medical Director, Mass General Substance Use Disorder Initiative Assistant Professor, Harvard Medical School Disclosures

More information

The Chronic Disease of Addiction Evidence and Lessons from Practice

The Chronic Disease of Addiction Evidence and Lessons from Practice The Chronic Disease of Addiction Evidence and Lessons from Practice Laura G. Kehoe, MD, MPH Medical Director, MGH Substance Use Disorders Unit Bridge Clinic Massachusetts General Hospital Assistant Professor

More information

Attention-deficit Hyperactivity Disorder ADHD

Attention-deficit Hyperactivity Disorder ADHD Attention-deficit Hyperactivity Disorder ADHD Jan Buitelaar Radboud University Nijmegen Medical Center Donders Institute for Brain, Cognition and Behavior Department of Cognitive Neuroscience, and Karakter

More information

Mental Health and Behavioral Health

Mental Health and Behavioral Health Mental Health and Behavioral Health mpfc (AC) Insula Thal DS GP VS VS VTA VTA Hippo OFC Wilson M. Compton, M.D., M.P.E. Deputy Director National Institute on Drug Abuse Advancing Addiction Science Behavioral

More information

Scientific Facts on. Psychoactive Drugs. Tobacco, Alcohol, and Illicit Substances

Scientific Facts on. Psychoactive Drugs. Tobacco, Alcohol, and Illicit Substances page 1/5 Scientific Facts on Psychoactive Drugs Tobacco, Alcohol, and Illicit Substances Source document: WHO (2004) Summary & Details: GreenFacts Context - Psychoactive drugs such as tobacco, alcohol,

More information

ine) on (% Baseli Concentratio DA C

ine) on (% Baseli Concentratio DA C Chemical Dependency Relapse Pathways Relapse Prevention Medications Understanding the how, why, where and when. Acknowledgements La Hacienda Treatment Center American Society of Addiction Medicine National

More information

Neurocircuitry Of Suicidal Behavior In Adolescents And Young Adults With Bipolar And Major Depressive Disorder

Neurocircuitry Of Suicidal Behavior In Adolescents And Young Adults With Bipolar And Major Depressive Disorder Yale University EliScholar A Digital Platform for Scholarly Publishing at Yale Yale Medicine Thesis Digital Library School of Medicine January 2015 Neurocircuitry Of Suicidal Behavior In Adolescents And

More information

Addiction Overview. Diane A. Rothon MD. Causes Consequences Treatments. Methadone/Buprenorphine 101 April 1, 2017

Addiction Overview. Diane A. Rothon MD. Causes Consequences Treatments. Methadone/Buprenorphine 101 April 1, 2017 Addiction Overview Causes Consequences Treatments Methadone/Buprenorphine 101 April 1, 2017 Diane A. Rothon MD Why? would you listen to this presentation Review the definition and neurobiology of addiction

More information

Effectively Addressing Co-Occurring Nicotine Dependence and Marijuana Use. Chad Morris, PhD March 7, 2018

Effectively Addressing Co-Occurring Nicotine Dependence and Marijuana Use. Chad Morris, PhD March 7, 2018 Effectively Addressing Co-Occurring Nicotine Dependence and Marijuana Use Chad Morris, PhD March 7, 2018 2018 BHWP Behavioral Causes of Death in U.S. 2018 BHWP 2018 BHWP Health Disparities Population Behavioral

More information

Medication-Assisted Treatment and HIV/AIDS: Aspects in Treating HIV- Infected Drug Users.

Medication-Assisted Treatment and HIV/AIDS: Aspects in Treating HIV- Infected Drug Users. Slide #1 Medication-Assisted Treatment and HIV/AIDS: Aspects in Treating HIV- Infected Drug Users. R. Douglas Bruce, MD, MA, MSc Assistant Professor Yale AIDS Program Medical Director South Central Rehabilitation

More information

Part IV: Slipping Up: Neuroscience Basis of Relapse & Recovery July 31, am 12:30 pm with Break 10-10:15am

Part IV: Slipping Up: Neuroscience Basis of Relapse & Recovery July 31, am 12:30 pm with Break 10-10:15am Eighth Edition Congratulations and Thank You All for Attending Part IV: Slipping Up: Neuroscience Basis of Relapse & Recovery July 31, 2015 8 am 12:30 pm with Break 10-10:15am Preventing Recrudescence

More information

Report to The Vermont Legislature. Substance Abuse Treatment Services Objectives and Performance Measures Progress: Second Annual Report

Report to The Vermont Legislature. Substance Abuse Treatment Services Objectives and Performance Measures Progress: Second Annual Report Report to The Vermont Legislature Substance Abuse Treatment Services Objectives and Performance Measures Progress: Second Annual Report In Accordance with Act 179 () Sec. E.306.2 (a)(2) Submitted to: Submitted

More information

Neuroimaging Findings in Young Drinkers: Does Teenage Drinking Harm the Brain? Susan F. Tapert, Ph.D. University of California, San Diego

Neuroimaging Findings in Young Drinkers: Does Teenage Drinking Harm the Brain? Susan F. Tapert, Ph.D. University of California, San Diego Neuroimaging Findings in Young Drinkers: Does Teenage Drinking Harm the Brain? Susan F. Tapert, Ph.D. University of California, San Diego 2 Overview What is normal adolescence? How do binge drinkers differ?

More information

Main Questions. Why study addiction? Substance Use Disorders, Part 1 Alecia Schweinsburg, MA Abnromal Psychology, Fall Substance Use Disorders

Main Questions. Why study addiction? Substance Use Disorders, Part 1 Alecia Schweinsburg, MA Abnromal Psychology, Fall Substance Use Disorders Substance Use Disorders Main Questions Why study addiction? What is addiction? Why do people become addicted? What do alcohol and drugs do? How do we treat substance use disorders? Why study addiction?

More information

Figure 1. National Drug Overdose Deaths Number Among All Ages, by Gender,

Figure 1. National Drug Overdose Deaths Number Among All Ages, by Gender, Figure 1. National Drug Overdose Deaths Number Among All Ages, by Gender, -217 1, Total Overdose Deaths Male Female 8, 7,237 6, 4, 16,849 2 21 22 23 24 36,1 25 26 27 28 29 21 211 212 213 214 215 216 217-217

More information

Trends and Challenges: The Kentucky Opioid Crisis. Jason Smith, MD PhD University of Louisville

Trends and Challenges: The Kentucky Opioid Crisis. Jason Smith, MD PhD University of Louisville Trends and Challenges: The Kentucky Opioid Crisis Jason Smith, MD PhD University of Louisville Brief Introduction I am by no means an expert I have no financial disclosures Jokes are meant to be lighthearted

More information

Key Concepts. Machinery of the Mind. The Growing Cycle. Six Brain Mind Functions. Machinery of the Mind 6/1/2012

Key Concepts. Machinery of the Mind. The Growing Cycle. Six Brain Mind Functions. Machinery of the Mind 6/1/2012 Machinery of the Mind How High-risk Choices Redesign the Brain Key Concepts Brain and Mind are reciprocal Brain/Mind Functions intertwine We are hardwired and we have software Your brain changes all the

More information

Supplementary Appendix

Supplementary Appendix Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Volkow ND, Koob GF, McLellan AT. Neurobiologic advances from

More information

Advancing Addiction Science to Address the Opioid Crisis

Advancing Addiction Science to Address the Opioid Crisis Advancing Addiction Science to Address the Opioid Crisis National Institute on Drug Abuse Bringing the full power of science to bear on drug abuse and addiction Nora D. Volkow, M.D. Director National Institute

More information

Imaging in Pediatric `neurohiv Dr Jackie Hoare Head of Liaison Psychiatry Groote Schuur Hospital, UCT

Imaging in Pediatric `neurohiv Dr Jackie Hoare Head of Liaison Psychiatry Groote Schuur Hospital, UCT Imaging in Pediatric `neurohiv Dr Jackie Hoare Head of Liaison Psychiatry Groote Schuur Hospital, UCT ? Spectrum of Neurocognitive disorders The adult literature on HIV related CNS damage supports a spectrum

More information